US 12679833 — Patent Expiration

N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS

Shareable link — bookmark or send to anyone

www.patentreply.ai/tools/patent-expiration/US12679833

Important: This calculator does not include patent term extension under 35 U.S.C. § 156, which may apply to certain drug, biologic, animal drug, and medical device patents.

Learn how PTE is calculated

US 12679833

N-cyanopyrrolidines With Activity As Usp30 Inhibitors

High Confidence

Application No. 18007641

April 11, 2043

16y 262d remaining

Could not fetch continuity data for application PCTEP2021064897: Resource not found (404)

Earliest effective filing

Jun 3, 2021

+ 20 years

Jun 3, 2041

PTA +677d

Apr 11, 2043

No TD

—

Final

Apr 11, 2043

This calculation includes Patent Term Adjustment (PTA) under 35 U.S.C. §154(b). Patent Term Extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation Details

Base Term Calculation

Filing Date

December 1, 2022

Earliest Effective Filing

June 3, 2021

Issue Date

July 14, 2026

PTA

+677 days

Base Expiry (before PTA)

June 3, 2041

June 3, 2021 + 20 years = June 3, 2041 + 677 PTA days = April 11, 2043

National Stage Entry of application PCTEP2021064897, filed Jun 3, 2021

Terminal Disclaimer Analysis

No TD

0 approved, 0 filed

Who owns this patent?

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.